# SYMJEPI
> **NDA207534** · New Drug Application · Sponsor: ADAMIS PHARMS CORP · Approved 2017-06-15
## Drug
- **FDA Application Number:** NDA207534
- **Application type:** New Drug Application
- **Brand name:** SYMJEPI
- **Generic name:** Epinephrine
- **Active ingredients:** EPINEPHRINE
- **Dosage form:** SOLUTION
- **Route:** INTRAMUSCULAR, SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** ADAMIS PHARMS CORP
- **First approval:** 2017-06-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207534)
---
*AI Analytics · CC0 1.0*